{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:27:51Z","timestamp":1786991271240,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jad.2017.09.034","type":"journal-article","created":{"date-parts":[[2017,9,30]],"date-time":"2017-09-30T12:02:26Z","timestamp":1506772946000},"page":"245-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Allopurinol augmentation in acute mania: A meta-analysis of placebo-controlled trials"],"prefix":"10.1016","volume":"226","author":[{"given":"Alexander T.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Malmstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry A.","family":"Nasrallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2017.09.034_bib1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1399-5618.2006.00363.x","article-title":"Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial","volume":"8","author":"Akhondzadeh","year":"2006","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.09.034_bib2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pnpbp.2004.11.008","article-title":"Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial","volume":"29","author":"Akhondzadeh","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.034_bib3","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(68)92300-3","article-title":"Uric-acid metabolism in manic-depressive illness and during lithium therapy","volume":"1","author":"Anumonye","year":"1968","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2017.09.034_bib4","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.0307921101","article-title":"Lithium antagonizes dopamine-dependent behaviors mediated by an AKT\/glycogen synthase kinase 3 signaling cascade","volume":"101","author":"Beaulieu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jad.2017.09.034_bib5","first-page":"671","article-title":"Serotonin, folic acid, and uric acid metabolism in the diagnosis of neuropsychiatric disorders","volume":"13","author":"Brooks","year":"1978","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.034_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4088\/JCP.v66n0209","article-title":"A clinical trial of adjuvant allopurinol therapy for moderately refractory schizophrenia","volume":"66","author":"Brunstein","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.034_bib7","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1345\/aph.1H222","article-title":"Allopurinol as adjuvant therapy in poorly responsive or treatment refractory schizophrenia","volume":"40","author":"Buie","year":"2006","journal-title":"Ann. Pharmacother."},{"issue":"1","key":"10.1016\/j.jad.2017.09.034_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00861588","article-title":"Gout, uric acid and purine metabolism in paediatric nephrology","volume":"7","author":"Cameron","year":"1993","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.jad.2017.09.034_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.psychres.2009.07.012","article-title":"Increased risk of gout among patients with bipolar disorder: a nationwide population-based study","volume":"180","author":"Chung","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2017.09.034_bib10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2165\/00003088-200746080-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol","volume":"46","author":"Day","year":"2007","journal-title":"Clin. Pharmacokinet."},{"issue":"7","key":"10.1016\/j.jad.2017.09.034_bib11","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0028-3908(02)00215-0","article-title":"Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium","volume":"43","author":"De Sarno","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2017.09.034_bib12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.schres.2008.12.028","article-title":"A double-blind trial of adjunctive allopurinol for schizophrenia","volume":"109","author":"Dickerson","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2017.09.034_bib13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1399-5618.2012.01001.x","article-title":"Allopurinol augmentation in the outpatient treatment of bipolar mania: a pilot study","volume":"14","author":"Fan","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.09.034_bib14","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1111\/j.1755-5949.2009.00126.x","article-title":"Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders","volume":"16","author":"Fuxe","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jad.2017.09.034_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.mp.4001793","article-title":"Treatment-resistant bipolar disorder","volume":"11","author":"Gitlin","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.034_bib16","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.euroneuro.2014.05.013","article-title":"In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder","volume":"24","author":"Jahangard","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2017.09.034_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tibs.2003.12.004","article-title":"The glamour and gloom of glycogen synthase kinase-3","volume":"29","author":"Jope","year":"2004","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jad.2017.09.034_bib18","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2174\/1389450110607011421","article-title":"Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions","volume":"7","author":"Jope","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jad.2017.09.034_bib19","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.nbd.2009.11.010","article-title":"Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients","volume":"37","author":"Kim","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jad.2017.09.034_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1054\/mehy.2001.1543","article-title":"Purinergic dysfunction in mania: an integrative model","volume":"58","author":"Machado-Vieira","year":"2002","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jad.2017.09.034_bib21","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4088\/JCP.v69n0806","article-title":"A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania","volume":"69","author":"Machado-Vieira","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.034_bib22","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2017.09.034_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/pr.58.1.6","article-title":"Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.jad.2017.09.034_bib24","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.pnpbp.2010.02.027","article-title":"Increased uric acid levels in drug-na\u00efve subjects with bipolar disorder during first manic episode","volume":"34","author":"Salvadore","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.034_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1017\/S0033291703001090","article-title":"Lower high-density lipoprotein cholesterol and increased omega-6 polyunsaturated fatty acids in first-degree relatives of bipolar patients","volume":"34","author":"Sobczak","year":"2004","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2017.09.034_bib26","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/978-3-540-89615-9_17","article-title":"Adenosine receptors and neurological disease: neuroprotection and neurodegeneration","author":"Stone","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"issue":"Suppl 5","key":"10.1016\/j.jad.2017.09.034_bib27","first-page":"S31","article-title":"Management of acute mania","volume":"60","author":"Tohen","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.034_bib28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/bdi.12202","article-title":"Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and\/or antipsychotic agents in manic patients with bipolar disorder","volume":"16","author":"Weiser","year":"2014","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.09.034_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.schres.2012.02.014","article-title":"A randomized controlled trial of allopurinol vs. placebo added on to antipsychotics in patients with schizophrenia or schizoaffective disorder","volume":"138","author":"Weiser","year":"2012","journal-title":"Schizophr. Res."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717305384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717305384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T01:19:40Z","timestamp":1574990380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032717305384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":29,"alternative-id":["S0165032717305384"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2017.09.034","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allopurinol augmentation in acute mania: A meta-analysis of placebo-controlled trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2017.09.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}